BRVE Braveheart Bio, Inc.
Healthcare · Market cap: not available
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $159.0M | $0 |
| 2026-Q4 | $0 | $0 |
Bought$159.0M10 buy days
Sold$00 sell days
Net insider flow+$159.0Mnet buying · 5 years
Latest trade2026-08-07Forbion Growth III Management B.V.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-08-07 | Buy | Forbion Growth III Management B.V. | 10% owner | 3,600,000 | $18.00 | $64.8M | 2 |
| 2026-08-07 | Buy | Chimovits Erez | Director | 1,940,000 | $18.00 | $34.9M | 2 |
| 2026-08-07 | Buy | ORBIMED ADVISORS LLC | Director | 1,940,000 | $18.00 | $34.9M | 2 |
| 2026-08-07 | Buy | Andreessen Marc L | 10% owner | 1,100,000 | $18.00 | $19.8M | 1 |
| 2026-08-07 | Buy | Murdoch Travis | CEO | 83,333 | $18.00 | $1.5M | 1 |
| 2026-08-07 | Buy | Viehbacher Christopher | Director | 83,333 | $18.00 | $1.5M | 1 |
| 2026-08-07 | Buy | Lubner David Charles | Director | 55,555 | $18.00 | $1,000.0K | 1 |
| 2026-08-07 | Buy | Rickey James Paul | CFO | 27,777 | $18.00 | $500.0K | 1 |
| 2026-08-07 | Buy | Malek David I | Director | 4,166 | $18.00 | $75.0K | 1 |
| 2026-08-07 | Buy | Anderson Michele A. | Other C-suite | 1,111 | $18.00 | $20.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Forbion Growth III Management B.V. | 10% owner | $64.8M | $0 | 2026-08-07 |
| Chimovits Erez | Director | $34.9M | $0 | 2026-08-07 |
| ORBIMED ADVISORS LLC | Director | $34.9M | $0 | 2026-08-07 |
| Andreessen Marc L | 10% owner | $19.8M | $0 | 2026-08-07 |
| Murdoch Travis | CEO | $1.5M | $0 | 2026-08-07 |
| Viehbacher Christopher | Director | $1.5M | $0 | 2026-08-07 |
| Lubner David Charles | Director | $1,000.0K | $0 | 2026-08-07 |
| Rickey James Paul | CFO | $500.0K | $0 | 2026-08-07 |
| Malek David I | Director | $75.0K | $0 | 2026-08-07 |
| Anderson Michele A. | Other C-suite | $20.0K | $0 | 2026-08-07 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-08-07 | 10 | $159.0M | 63 | – | – | – | active |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.